Analysis backs combined hormone therapy, breast cancer link

04/1/2013 | HealthDay News

An analysis of data from the Women's Health Initiative found that postmenopausal women who took estrogen and progestin were more likely to develop breast cancer. The risk of breast cancer was about three times higher among women who started taking the hormones within months of menopause compared with those who waited 10 years. The study appeared in the Journal of the National Cancer Institute.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC